| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FNKO | Option to Purchase Class A Common Stock | Options Exercise | $0 | -7.53K | -21.88% | $0.00 | 26.9K | Jan 2, 2025 | CLASS A COMMON STOCK | 7.53K | $9.77 | Direct | F4, F5 |
| transaction | FNKO | Option to Purchase Class A Common Stock | Options Exercise | $0 | -358 | -1.33% | $0.00 | 26.5K | Jan 6, 2025 | CLASS A COMMON STOCK | 358 | $9.77 | Direct | F4, F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 16, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.43 to $14.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote |
| F3 | The total number of Class A Common Stock reported in Column 5 does not reflect any common units beneficially owned by the Reporting Person. |
| F4 | Shares were exercised pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 16, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| F5 | The option has vested and become exercisable with respect to 25% of the original grant of 34,400 shares subject thereto on the first anniversary of March 6, 2023 and the remaining 75% of the option will vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. |